- Home
- COLL vs SAFT Comparison
COLL vs SAFT Comparison
Compare COLL & SAFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- SAFT
- Stock Information
- Founded
- COLL 2002
- SAFT 1979
- Country
- COLL United States
- SAFT United States
- Employees
- COLL 357
- SAFT N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- SAFT Property-Casualty Insurers
- Sector
- COLL Health Care
- SAFT Finance
- Exchange
- COLL Nasdaq
- SAFT Nasdaq
- Market Cap
- COLL 1.1B
- SAFT 1.0B
- IPO Year
- COLL 2015
- SAFT N/A
- Fundamental
- Price
- COLL $34.62
- SAFT $67.63
- Analyst Decision
- COLL Strong Buy
- SAFT
- Analyst Count
- COLL 4
- SAFT 0
- Target Price
- COLL $44.25
- SAFT N/A
- AVG Volume (30 Days)
- COLL 319.8K
- SAFT 63.2K
- Earning Date
- COLL 11-06-2025
- SAFT 10-28-2025
- Dividend Yield
- COLL N/A
- SAFT 5.46%
- EPS Growth
- COLL N/A
- SAFT 65.99
- EPS
- COLL 1.06
- SAFT 5.73
- Revenue
- COLL $707,007,000.00
- SAFT $1,199,774,000.00
- Revenue This Year
- COLL $21.29
- SAFT N/A
- Revenue Next Year
- COLL $3.36
- SAFT N/A
- P/E Ratio
- COLL $32.88
- SAFT $11.75
- Revenue Growth
- COLL 22.61
- SAFT 16.96
- 52 Week Low
- COLL $23.23
- SAFT $67.04
- 52 Week High
- COLL $39.95
- SAFT $90.00
- Technical
- Relative Strength Index (RSI)
- COLL 49.72
- SAFT 35.23
- Support Level
- COLL $34.46
- SAFT $67.04
- Resistance Level
- COLL $35.90
- SAFT $70.49
- Average True Range (ATR)
- COLL 0.97
- SAFT 1.30
- MACD
- COLL 0.19
- SAFT -0.10
- Stochastic Oscillator
- COLL 69.18
- SAFT 17.22
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile, commercial automobile, and homeowners insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.